Wuxi, China · Founded 2018 · Privately Held (backing)
Manufacturer of life sciences raw materials designed to support research and development in biotechnology and molecular medicine. Synthgene is based in Wuxi, China and was founded in 2018. It has raised $46.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$46.8M
Last round
—
Cap table — not yet on record
Synthgene's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Synthgene with a free account
·The complete investor list: 14 names
·Watch Synthgene: the Monday email on marks, rounds and moves
